Interventions to reduce haemorrhage duringmyomectomy for fibroids (Review)
Background: Benign smoothmuscle tumours of the uterus, known as fibroids ormyomas, are often symptomless.However, about one-third ofwomen with fibroids will present with symptoms that are severe enough to warrant treatment. The standard treatment of symptomatic fibroids is hysterectomy (that is surgical removal of the uterus) for women who have completed childbearing, and myomectomy for women who desire future childbearing or simply want to preserve their uterus. Myomectomy, the surgical removal of myomas, can be associated with life-threatening bleeding. Excessive bleeding can necessitate emergency blood transfusion. Knowledge of the effectiveness of the interventions to reduce bleeding during myomectomy is essential to enable evidence-based clinical decisions. This is an update of the review published in The Cochrane Library (2011, Issue 11). Objectives: To assess the effectiveness, safety, tolerability and costs of interventions to reduce blood loss during myomectomy.